Chapin Davis Inc. Sells 6,066 Shares of Axon Enterprise, Inc $AXON

Chapin Davis Inc. lowered its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 90.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 644 shares of the biotechnology company’s stock after selling 6,066 shares during the period. Chapin Davis Inc.’s holdings in Axon Enterprise were worth $462,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently made changes to their positions in the company. Banque Transatlantique SA acquired a new position in Axon Enterprise during the 1st quarter worth approximately $31,000. Flaharty Asset Management LLC bought a new stake in shares of Axon Enterprise during the first quarter valued at approximately $33,000. Hemington Wealth Management raised its position in shares of Axon Enterprise by 70.8% during the second quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 17 shares during the period. Whipplewood Advisors LLC raised its position in shares of Axon Enterprise by 192.9% during the second quarter. Whipplewood Advisors LLC now owns 41 shares of the biotechnology company’s stock worth $34,000 after purchasing an additional 27 shares during the period. Finally, Darwin Wealth Management LLC bought a new position in shares of Axon Enterprise in the 2nd quarter worth $37,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 1,797 shares of the company’s stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $539.23, for a total value of $968,996.31. Following the completion of the transaction, the insider owned 83,485 shares in the company, valued at $45,017,616.55. This represents a 2.11% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Brittany Bagley sold 5,000 shares of Axon Enterprise stock in a transaction on Monday, September 29th. The stock was sold at an average price of $713.88, for a total value of $3,569,400.00. Following the sale, the chief financial officer owned 93,592 shares in the company, valued at $66,813,456.96. The trade was a 5.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 64,406 shares of company stock valued at $38,521,038. 4.40% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

AXON has been the subject of a number of recent research reports. Morgan Stanley decreased their price target on shares of Axon Enterprise from $760.00 to $713.00 and set an “overweight” rating for the company in a research note on Wednesday. Needham & Company LLC reiterated a “buy” rating and set a $870.00 price objective on shares of Axon Enterprise in a report on Wednesday, September 24th. Barclays decreased their target price on shares of Axon Enterprise from $861.00 to $702.00 and set an “overweight” rating for the company in a research report on Thursday, November 6th. Piper Sandler dropped their price target on shares of Axon Enterprise from $893.00 to $753.00 and set an “overweight” rating on the stock in a research report on Wednesday, November 5th. Finally, Royal Bank Of Canada assumed coverage on Axon Enterprise in a research note on Monday, November 17th. They set an “outperform” rating and a $860.00 price target for the company. Fourteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $802.71.

Axon Enterprise Trading Up 2.4%

Shares of AXON stock opened at $563.28 on Friday. The company has a debt-to-equity ratio of 0.57, a quick ratio of 2.89 and a current ratio of 3.12. The company has a market capitalization of $44.45 billion, a price-to-earnings ratio of 178.25, a PEG ratio of 126.32 and a beta of 1.40. Axon Enterprise, Inc has a 52-week low of $469.24 and a 52-week high of $885.91. The company has a 50-day simple moving average of $610.39 and a two-hundred day simple moving average of $709.16.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Wednesday, November 5th. The biotechnology company reported $1.17 earnings per share for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.46). The business had revenue of $710.64 million during the quarter, compared to analysts’ expectations of $704.83 million. Axon Enterprise had a return on equity of 4.29% and a net margin of 10.05%.Axon Enterprise’s quarterly revenue was up 30.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.45 EPS. Research analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.